Eli Lilly and Company has appointed Joshua Smiley as senior vice president, finance, and treasurer, effective on October 1. Mr. Smiley will replace Thomas Grein, who will retire in September, and will report to Derica Rice, executive vice president, global services, and chief financial officer.
Mr. Smiley currently serves as senior vice president, finance, and controller and chief financial officer for Lilly Research Laboratories (LRL). Succeeding Mr. Smiley will be Anat Ashkenazi, vice president, finance, and chief financial officer for Lilly Manufacturing, Global Quality and Lilly Diabetes.
Mr. Smiley has been with Lilly 21 years, serving in a variety of financial, marketing, and Six Sigma roles. He has been in his current role since 2011 and before that was vice president, finance, and chief financial officer for LRL and Lilly Oncology.
Ms. Ashkenazi joined Lilly 15 years ago. Her career has focused on finance, corporate strategy, business development, and Six Sigma. Before assuming her current role, she was senior director, finance, and chief financial officer for Lilly Oncology.
Source: Eli Lilly and Company